Screener
Sionna Therapeutics SION Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -26.7%— | —— | —— | —— | —— | |
| Return on invested capital | -38.8%— | —— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 22.6×-6.1× | 20.6×+6.1× | 25.6×— | 35.3×— | 28.7×— | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×— | 0×— | 0×— | 0×— | |
| Per Share | ||||||
| Book value per share | $6.42-51.5% | $7.68+118% | $7.27+122% | $7,625.84+118% | $13.23+100% | |
| Valuation | ||||||
| Market capitalization | $221.54M-82.3% | $1.84B— | $1.3B— | $707.24M— | —— | |
| Price / book | 0.8×-3.1× | 6×— | 4×— | 2.1×— | —— |
FAQ
- Where do Sionna Therapeutics's ratios come from?
- Every ratio is computed from Sionna Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.